Sanofi
SNYNF
$84.97
-$1.67-1.93%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | 6.80B | 3.52B | 2.78B | |
| Total Depreciation and Amortization | -- | 3.18B | 3.16B | 3.62B | |
| Total Amortization of Deferred Charges | -- | 59.02M | -- | -- | |
| Total Other Non-Cash Items | -- | -1.06B | 3.94B | 2.11B | |
| Change in Net Operating Assets | -- | -695.71M | -- | -- | |
| Cash from Operations | -- | 7.75B | 7.52B | 5.42B | |
| Capital Expenditure | -- | -959.01M | -- | -- | |
| Sale of Property, Plant, and Equipment | -- | 492.56M | -- | -- | |
| Cash Acquisitions | -- | -610.59M | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | -- | 12.95B | 192.01M | 604.79M | |
| Cash from Investing | -- | 9.55B | -4.50B | -4.09B | |
| Total Debt Issued | -- | 6.32B | -- | -- | |
| Total Debt Repaid | -- | -1.98B | -- | -- | |
| Issuance of Common Stock | -- | 29.00M | -- | -- | |
| Repurchase of Common Stock | -- | -4.00B | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -5.42B | -- | -- | |
| Other Financing Activities | -- | 1.69B | 385.00M | 1.74B | |
| Cash from Financing | -- | -9.19B | -5.50B | -4.05B | |
| Foreign Exchange rate Adjustments | -- | -30.19M | -13.79M | 1.83M | |
| Miscellaneous Cash Flow Adjustments | -- | 201.20M | -163.11M | -- | |
| Net Change in Cash | -- | 8.10B | -2.83B | -2.90B | |